Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia.

ADH, autosomal dominant hypercholesterolemia AUC, area under the plasma concentration−time curve BBR, berberine CHD, coronary heart disease CL, clearance CVDs, cardiovascular diseases Cmax, maximum concentration DiI-LDL, low-density lipoprotein, labeled with 1,1′-dioctadecyl-3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate F, oral bioavailability FDA, food and drug administration HFD, high-fat diet Hyperlipidemia hamster LDL-C, low-density lipoprotein-cholesterol LDLR, low-density lipoprotein receptor Lipid-lowering Low-density lipoprotein cholesterol Low-density lipoprotein receptor MRT, mean residence time PCSK9 PCSK9 expression PCSK9, proprotein convertase subtilisin/kexin type 9 PK, pharmacokinetic POCl3, phosphoryl trichloride TC, total cholesterol THPBs, tetrahydroprotoberberine derivatives Tetrahydroprotoberberine derivatives Total cholesterol hERG, human ether-à-go-go related gene mAbs, monoclonal antibodies t1/2, half-life

Journal

Acta pharmaceutica Sinica. B
ISSN: 2211-3835
Titre abrégé: Acta Pharm Sin B
Pays: Netherlands
ID NLM: 101600560

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 28 03 2019
revised: 11 06 2019
accepted: 12 06 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 24 12 2019
Statut: ppublish

Résumé

Proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators may attenuate PCSK9-induced low-density lipoprotein receptor (LDLR) degradation in lysosome and promote the clearance of circulating low-density lipoprotein cholesterol (LDL-C). A novel series of tetrahydroprotoberberine derivatives (THPBs) were designed, synthesized, and evaluated as PCSK9 modulators for the treatment of hyperlipidemia. Among them, eight compounds exhibited excellent activities in downregulating hepatic PCSK9 expression better than berberine in HepG2 cells. In addition, five compounds

Identifiants

pubmed: 31867167
doi: 10.1016/j.apsb.2019.06.006
pii: S2211-3835(19)30426-5
pmc: PMC6900552
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1216-1230

Informations de copyright

© 2019 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.

Références

J Am Coll Cardiol. 2017 Jul 4;70(1):1-25
pubmed: 28527533
Am J Hum Genet. 2006 Sep;79(3):514-23
pubmed: 16909389
J Agric Food Chem. 2017 Aug 2;65(30):6152-6157
pubmed: 28689410
Eur J Med Chem. 2013 Oct;68:150-66
pubmed: 23974015
J Med Chem. 2016 Oct 27;59(20):9489-9502
pubmed: 27709945
Nat Med. 2004 Dec;10(12):1344-51
pubmed: 15531889
Pharm Biol. 2017 Dec;55(1):510-515
pubmed: 27937081
Nat Genet. 2003 Jun;34(2):154-6
pubmed: 12730697
Drug Metab Dispos. 2010 Oct;38(10):1779-84
pubmed: 20634337
J Neuroimmunol. 2015 Dec 15;289:43-55
pubmed: 26616870
Bioorg Med Chem. 2018 May 1;26(8):2017-2027
pubmed: 29545016
Bioorg Med Chem Lett. 2018 Apr 15;28(7):1155-1160
pubmed: 29519739
J Org Chem. 2009 Dec 4;74(23):9225-8
pubmed: 19950885
Biochim Biophys Acta. 2001 Oct 31;1533(3):220-32
pubmed: 11731332
N Engl J Med. 2015 Apr 16;372(16):1489-99
pubmed: 25773378
Phytochemistry. 2017 Apr;136:119-124
pubmed: 28139296
N Engl J Med. 2017 Jan 5;376(1):41-51
pubmed: 27959715
Bioorg Med Chem. 2013 Feb 15;21(4):856-68
pubmed: 23332346
J Agric Food Chem. 2017 Jul 5;65(26):5316-5321
pubmed: 28649844
PLoS Biol. 2017 Mar 21;15(3):e2001882
pubmed: 28323820
J Cardiovasc Pharmacol. 2006 Jan;47(1):21-9
pubmed: 16424781
Bioorg Med Chem. 2014 Nov 1;22(21):5838-46
pubmed: 25308766
Curr Opin Lipidol. 2014 Oct;25(5):387-93
pubmed: 25110901
Angew Chem Int Ed Engl. 2017 Dec 18;56(51):16218-16222
pubmed: 29073340
Eur J Med Chem. 2017 Nov 10;140:448-464
pubmed: 28987606
Atherosclerosis. 2008 Dec;201(2):266-73
pubmed: 18355829
Nat Prod Res. 2014;28(7):413-9
pubmed: 24422860
Angew Chem Int Ed Engl. 2008;47(21):3966-8
pubmed: 18393267
Eur Heart J. 2017 Aug 21;38(32):2459-2472
pubmed: 28444290
Phytomedicine. 2012 Jul 15;19(10):861-7
pubmed: 22739410
Acta Pharmacol Sin. 2014 Aug;35(8):994-1004
pubmed: 25042549
Bioorg Med Chem. 2012 Aug 1;20(15):4862-71
pubmed: 22748706
Lancet. 2012 Jul 7;380(9836):29-36
pubmed: 22633824
Bioorg Med Chem. 2013 Jan 1;21(1):62-9
pubmed: 23199480

Auteurs

Chenglin Wu (C)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
School of Pharmacy, China Pharmaceutical University, Nanjing 210009, China.

Cong Xi (C)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Junhua Tong (J)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Jing Zhao (J)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Hualiang Jiang (H)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Jiang Wang (J)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Yiping Wang (Y)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Hong Liu (H)

State Key Laboratory of Drug Research and CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
University of Chinese Academy of Sciences, Beijing 100049, China.

Classifications MeSH